您的位置: 首页 > 农业专利 > 详情页

Plasmonic nanoparticle immunoassay method
专利权人:
The General Hospital Corporation
发明人:
Conor L. Evans,W. Peter Hansen,Robert A. Hoffman,Petra B. Krauledat,Daniel W. Cramer
申请号:
US15556998
公开号:
US10571400B2
申请日:
2016.03.11
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A method for detecting a target cell surface molecule and classifying cell types in a fluid sample. The method involves the addition of a reagent to the fluid sample. The reagent includes nanoparticles with optical plasmonic resonances, and at least one fluorescent probe. The nanoparticles are a bio-optical probe for the target cell surface molecule. Each fluorescent probe targets a cell classification marker. The method further involves the acquisition of an image using dark field microscopy and fluorescence microscopy to detect and quantify the presence or absence of any cells in the fluid sample having the target cell surface molecule or having the cell classification marker.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充